BIOCAN DHPPi + L PLUS
BIOCAN DHPPi + L PLUS
Authorised
- Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
- Canine parvovirus, Live
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
- Leptospira interrogans, Serogroup Canicola, serovar Canicola, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
- Canine adenovirus 2, Live
- Canine distemper virus, strain CDVU 39, Live
Product identification
Medicine name:
BIOCAN DHPPi + L PLUS
Active substance:
- Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
- Canine parvovirus, Live
- Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
- Leptospira interrogans, Serogroup Canicola, serovar Canicola, Inactivated
- Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
- Canine adenovirus 2, Live
- Canine distemper virus, strain CDVU 39, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parainfluenza virus, strain CPiV-2-Bio 15, Live3.00/log10 50% tissue culture infectious dose1.00Dose
-
Canine parvovirus, Live3.00/log10 50% tissue culture infectious dose1.00Dose
-
Leptospira interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, Inactivated
-
Leptospira interrogans, Serogroup Canicola, serovar Canicola, Inactivated32.00/log2 geometric mean titre1.00Dose
-
Leptospira interrogans, serovar Icterohaemorrhagiae, Inactivated
-
Canine adenovirus 2, Live3.50/log10 50% tissue culture infectious dose1.00Dose
-
Canine distemper virus, strain CDVU 39, Live3.00/log10 50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI05AA
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2899
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 2/07/2023
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 2/07/2023
How useful was this page?:
